Publications

5600 Results

Ifosfamide (IFX) + cisplatin in the treatment of metastatic soft tissue sarcoma (SIS).

Authors
GT Budd;B Metch;S Weiss;JK Weick;R Stephens;C Fabian;S Balcerzak
Journal / Conference
ASCO 9:316(#1222)
Year
1990
Research Committee(s)
Sarcoma

DNA flow cytometry measurements are prognostic for the time to recurrence in node negative breast cancer: An Eastern Cooperative Group (ECOG) intergroup study.

Authors
LG Dressler;L Eudey;R Gray;DC Tormey;WL McGuire;CK Osborne;KW Gilchrist;EG Mansour;MD Abeloff
Journal / Conference
ASCO 9:22(#81)
Year
1990
Research Committee(s)
Breast
Study Number(s)
SWOG-8696 (INT-0076) (EST-7186)

A phase II trial of tumor necrosis factor in human sarcoma: A Southwest Oncology Group study.

Authors
J Rinehart;SP Balcerzak;E Hersh
Journal / Conference
ASCO 9:317(#1229)
Year
1990
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8742

A phase II study of recombinant tumor necrosis factor (rINF) in patients with metastatic colorectal adenocarcinoma. A Southwest Oncology Group study.

Authors
RP Whitehead;T Fleming;P Goodman;J Neefe;TJ Braun;LJ Swinnen;EM Hersh
Journal / Conference
ASCO 9:106(#411)
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8743

Recombinant tumor necrosis factor (rTNF) intolerance in pancreatic and gastric cancers: A Southwest Oncology Group study.

Authors
FM Muggia;T Brown;P Goodman;L Leichman;J Macdonald;EM Hersh
Journal / Conference
AACR 31:185(#1102)
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8755

Phase III study of cisplatin dose intensity in advanced germ cell tumors (GCT). A Southeastern and Southwest Oncology Group protocol.

Authors
L Einhorn;S Williams;P Loehrer;D Crawford;J Wettlaufer;A Bartolucci;L Schacter
Journal / Conference
ASCO 9:132(#510)
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8788

Phase II trial of pibenzimol in advanced pancreatic carcinoma. A Southwest Oncology Group study.

Authors
E Kraut;J Neidhart;J Macdonald
Journal / Conference
ASCO 9:130(#504)
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8800

A phase I study of the sequential combination of recombinant gamma-interferon (IFN7) and recombinant interleukin-2 (IL2) in patients with disseminated malignant disease.

Authors
CW Taylor;EM Chase;EM Hersh;JJ Rinehart;RP Whitehead;R Gonzalez;PA Bunn;J Neidhart
Journal / Conference
ASCO 9:192(#742)
Year
1990
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-8801

Prospective correlation of cytotoxic response and DNA content parameters in advanced squamous cell cancer of the head and neck (SCCHN).

Authors
J Ensley;Z Maciorowski;H Pietraszkiewicz;J Kish;E Tapazoglou;J Jacobs;R Mathog;W Sakr;M Al-Sarraf;B Metch;D Schuller;C Coltman, Jr
Journal / Conference
ASCO 9:173(#671)
Year
1990
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8855

Intravenous melphalan and GM-CSF: A phase I study.

Authors
E Poplin;B Redman;H Smith;S Balcerzak;DS Alberts
Journal / Conference
AACR 31:204(#1213)
Year
1990
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-8825